Prucalopride
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB06480 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | hypoalphalipoproteinemia | KG + DL |
| 2 | homozygous familial hypercholesterolemia | KG + DL |
| 3 | duodenal ulcer (disease) | KG + DL |
| 4 | oral candidiasis | KG + DL |
| 5 | obsolete familial combined hyperlipidemia | KG + DL |
| 6 | amyloidosis (disease) | KG + DL |
| 7 | strongyloidiasis | KG + DL |
| 8 | HIV infectious disease | KG + DL |
| 9 | primary amyloidosis | KG + DL |
| 10 | acquired amyloid peripheral neuropathy | KG + DL |
| 11 | dermis disease | KG + DL |
| 12 | multiple endocrine neoplasia | KG + DL |
| 13 | duodenal obstruction | KG + DL |
| 14 | macular amyloidosis | KG + DL |
| 15 | amyloidosis cutis dyschromia | KG + DL |
| 16 | nodular cutaneous amyloidosis | KG + DL |
| 17 | commissural lip fistula | KG + DL |
| 18 | osteoradionecrosis of the mandible | KG + DL |
| 19 | oral leukoedema | KG + DL |
| 20 | burning mouth syndrome | KG + DL |
| 21 | duodenogastric reflux | KG + DL |
| 22 | myositis | KG + DL |
| 23 | paratenonitis | KG + DL |
| 24 | calcific tendinitis | KG + DL |
| 25 | methemoglobinemia | KG + DL |
| 26 | vitamin deficiency disorder | KG + DL |
| 27 | congestive heart failure | KG + DL |
| 28 | feline acquired immunodeficiency syndrome | KG + DL |
| 29 | simian immunodeficiency virus infection | KG + DL |
| 30 | thrombotic disease | KG + DL |
| 31 | herpes simplex virus keratitis | KG + DL |
| 32 | neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter | KG + DL |
| 33 | rheumatoid arthritis | KG + DL |
| 34 | AIDS | KG + DL |
| 35 | intracranial abscess | KG + DL |
| 36 | breast fibrocystic disease | KG + DL |
| 37 | headache disorder | KG + DL |
| 38 | biotin metabolic disease | KG + DL |
| 39 | acute pulmonary heart disease | KG + DL |
| 40 | infectious otitis media | KG + DL |
| 41 | middle ear cholesterol granuloma | KG + DL |
| 42 | leprosy | KG + DL |
| 43 | disease of orbital region | KG + DL |
| 44 | oral hairy leukoplakia | KG + DL |
| 45 | eye disease | KG + DL |
| 46 | trigeminal autonomic cephalalgia | KG + DL |
| 47 | otosalpingitis | KG + DL |
| 48 | allergic otitis media | KG + DL |
| 49 | middle ear disease | KG + DL |
| 50 | methemoglobinemia, alpha type | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.